Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma
- Conditions
- Injury TraumaticTrauma InjurySurvivorship
- Interventions
- Other: Human-Centered Injury Thrivorship Pathway
- Registration Number
- NCT06292039
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is:
• Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors?
Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 25
- Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
- Admitted to the hospital ≥ 24 hours
- Discharged from the hospital alive
- San Francisco resident or unhoused in San Francisco
- Capacity for informed consent
- Patient < 18 years old
- Deceased during index hospitalization
- Unable to provide informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Injury Thrivorship Pathway Human-Centered Injury Thrivorship Pathway Enrollment in the human-centered injury thrivorship pathway.
- Primary Outcome Measures
Name Time Method Early Implementation Outcomes - Acceptability, Appropriateness, Feasibility 8-12 weeks post-pathway enrollment Early implementation outcomes will be assessed via purposive sampling of pathway participants, their caregivers, and trauma care stakeholders for in-depth semi-structured interviews. "Acceptability is the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Appropriateness is the perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Feasibility is defined as the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting."
- Secondary Outcome Measures
Name Time Method Participant pathway resource utilization - type 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year Participant engagement with applicable pathway resources will be tracked by type of resource(s) accessed
Participant pathway resource utilization - frequency 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year Participant engagement with applicable pathway resources will be tracked by frequency of use of the resource(s)
Participant pathway resource utilization - % utilized 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year Participant engagement with applicable pathway resources will be tracked by overall % of resources utilized out of resource(s) offered
Participant pathway resource utilization - duration 8-12 weeks post-pathway enrollment plus subsequent time points if continued resource engagement until study completion up to 1 year Participant engagement with applicable pathway resources will be tracked by duration of use of the resource(s)
Trial Locations
- Locations (1)
Zuckerberg San Francisco General Hospital
🇺🇸San Francisco, California, United States